TrialCancer medicine2020

Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients.

Andrew Belch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.